GlassScriptPhysician profile
Cynthia H Brown
NPI 1841382322
$9,633.08
in general payments reported to CMS, 2019-2025
27 companies · $58.69 in 2025
The $58.69 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,770 · 2020: $72.85 · 2021: $61.38 · 2022: $54.14 · 2023: $247 · 2024: $3,369 · 2025: $58.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $471 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $470.97 |
| Travel and Lodging | $203.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $5,416.21 | 2019 | |
| Intuitive Surgical, INC. | $3,243.85 | 2024 | |
| Abbvie INC. | $124.26 | 2019-2022 | |
| Medtronic, INC. | $104.00 | 2023-2024 | Truclear |
| Myriad Women'S Health, INC. | $79.65 | 2023 | Myrisk |
| Shield Therapeutics INC | $56.94 | 2024-2025 | |
| Becton, Dickinson and Company | $56.83 | 2019 | |
| Astellas Pharma US INC | $51.31 | 2019-2023 | Veozah |
| Therapeuticsmd, INC. | $50.14 | 2019-2022 | |
| Pfizer INC. | $47.52 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $43.65 | 2023 | Seglentis |
| Coopersurgical, INC. | $39.35 | 2019 | |
| Mylan Pharmaceuticals INC. | $37.69 | 2019-2022 | |
| Ethicon US, LLC | $36.57 | 2024-2025 | Stratafix, Surgiflo Hemostatic Matrix, Enseal |
| Sumitomo Pharma America, INC. | $34.89 | 2023 | Gemtesa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $33.59 | 2019-2020 | |
| Agile Therapeutics, INC. | $32.65 | 2021-2022 | |
| Sage Therapeutics, LLC | $26.66 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $16.08 | 2019 | |
| Merck Sharp & Dohme LLC | $14.36 | 2019 | |
| Teleflex LLC | $13.69 | 2021 | |
| Mayne Pharma Commercial LLC | $12.80 | 2023 | |
| Amag Pharmaceuticals, INC. | $12.47 | 2019 | |
| Exeltis, USA INC. | $12.33 | 2019 | |
| Minerva Surgical, INC | $12.29 | 2021 | |
| Covidien LP | $11.74 | 2019 | |
| Avion Pharmaceuticals | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.